Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,823 across all filing types
Latest filing 2020-02-21 AGM Information
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Genmab Board of Directors Chairman to Step Down
AGM Information Classification · 98% confidence The document is titled "Company Announcement" and explicitly states that the Chairman of the Board of Directors has decided to step down at the upcoming Annual General Meeting (AGM) on March 26, 2020. It also discusses the intention to appoint a new Chairman and nominate a new candidate for election at the AGM. This content directly relates to the governance and proceedings of the Annual General Meeting. Although it mentions the AGM date, the core subject is the change in board composition tied to that meeting, making it highly relevant to AGM materials. Since it is an announcement about the meeting's proceedings and changes, AGM-R (AGM Information) is the most appropriate classification, as it covers presentations and materials shared during the AGM, which often includes board changes.
2020-02-21 English
Genmab Publishes 2019 Annual Report
Report Publication Announcement Classification · 100% confidence The document is a company announcement titled 'Genmab Publishes 2019 Annual Report'. It explicitly states that the full report is attached as a PDF file and provides a link to it. Following the 'Menu vs Meal' rule, since this is a short announcement (under 5,000 characters of core content excluding boilerplate) that serves to notify the public of the publication of a report rather than being the report itself, it is classified as a Report Publication Announcement (RPA).
2020-02-19 English
Annual Report 2019
Annual Report Classification · 100% confidence The document is clearly identified as an 'Annual Report 2019' for Genmab. It contains a comprehensive table of contents, management's review, financial statements, and auditor's report, which are characteristic of a full annual report. It is not an announcement of a report (RPA) because it contains the full content of the report itself. FY 2019
2020-02-19 English
Genmab Publishes 2019 Annual Report
Earnings Release Classification · 99% confidence The document explicitly states: 'Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2019.' It then provides a summary of the business progress, financial performance for 2019, and the outlook for 2020. This content strongly suggests the document is related to the Annual Report (10-K or AR). However, the document is structured as a press release announcing the publication, mentioning that the 'full report is attached as a PDF file' and providing conference call details. According to Rule 2, when a document is short (this one is 10,843 chars, which is relatively short for a full 10-K) and announces the publication of a report while providing a link to the attachment, it should be classified as a Report Publication Announcement (RPA). The document's primary function here is to announce the release of the 2019 Annual Report, not to be the full, detailed regulatory filing itself. FY 2019
2020-02-19 English
Report Publication Announcement 2020
Report Publication Announcement Classification · 100% confidence The document is explicitly titled "Genmab Publishes 2019 Annual Report" and contains a summary of business progress, financial performance for 2019, and the financial outlook for 2020, including detailed financial tables comparing 2019 actuals to 2020 guidance. Although it is an announcement *about* the report, the content provided is a substantial summary of the full annual performance, which strongly aligns with the content expected in a 10-K or a comprehensive Annual Report. However, the document states, "The full report is attached as a PDF file and can be found on the investor section of the company's website." This structure—a summary announcement referencing the full attached report—suggests it functions primarily as a Report Publication Announcement (RPA) or a summary press release accompanying the formal filing. Given the comprehensive nature of the financial data summarized (full year results, detailed outlook, balance sheet metrics), it is more substantial than a typical ER or IR. Since the document is announcing the publication of the 'Annual Report' and provides significant financial detail, the most appropriate classification is the Annual Report (10-K) if the content were the full filing, but because it is an announcement *of* the publication, RPA is a strong candidate. However, in many contexts, the press release summarizing the 10-K is often classified alongside the 10-K itself, or if the content is extensive, it defaults to the report type. Given the explicit mention of 'Annual Report for 2019' and the detailed financial review, I will classify it as 10-K, recognizing the slight ambiguity due to the announcement format, but prioritizing the subject matter (full annual performance review). If the document were much shorter and only pointed to the report, RPA would be certain. Since the length is substantial (9578 chars) and contains the core financial narrative, 10-K is the best fit for the *subject* matter being presented, even if framed as a publication announcement.
2020-02-19 English
6-K Filing
Foreign Filer Report
2020-02-19 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.